Cellectar Biosciences (CLRB) Long-Term Investments (2017 - 2024)
Cellectar Biosciences' Long-Term Investments was $23,566 in Q1 2024, down 62.7% from $63,217 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Long-Term Investments (2017 - 2024) Analysis & Trends
From Q4 2017 onward, Cellectar Biosciences has reported Long-Term Investments for 24 quarters.
- Long-Term Investments shows a five-year compound annual growth rate of -46.6% (FY2018 to FY2023).
- In earlier years, Long-Term Investments was $75,000 in FY2022 (unchanged), $75,000 in FY2021 (unchanged), $75,000 in FY2020 (unchanged) and $75,000 in FY2019 (-86.1%).
- Quarterly Long-Term Investments has moved between $23,566 (Q2 2023) and $219,121 (Q3 2020) over five years.
- Compared with a year earlier, Long-Term Investments has declined for five straight quarters, with an average decline of 34.9% over the last eight quarters.
- The best year-over-year quarter for Long-Term Investments over five years was Q3 2020 (growth of 192.2%); the worst was Q3 2019 (a decline of 86.1%).
- Per Business Quant data, CLRB's Long-Term Investments in the three quarters before Q1 2024 was $23,566 (Q4 2023), $23,566 (Q3 2023) and $23,566 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Cellectar Biosciences | 22.51 Mn | 22.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 23,566.00 |
| Dec 31, 2023 | 23,566.00 |
| Sep 30, 2023 | 23,566.00 |
| Jun 30, 2023 | 23,566.00 |
| Mar 31, 2023 | 63,217.00 |
| Dec 31, 2022 | 75,000.00 |
| Sep 30, 2022 | 81,214.00 |
| Jun 30, 2022 | 81,214.00 |
| Mar 31, 2022 | 81,214.00 |
| Dec 31, 2021 | 75,000.00 |
| Sep 30, 2021 | 75,000.00 |
| Jun 30, 2021 | 75,000.00 |
| Mar 31, 2021 | 75,000.00 |
| Dec 31, 2020 | 75,000.00 |
| Sep 30, 2020 | 219,121.00 |
| Jun 30, 2020 | 81,214.00 |
| Mar 31, 2020 | 81,214.00 |
| Dec 31, 2019 | 75,000.00 |
| Sep 30, 2019 | 75,000.00 |
| Jun 30, 2019 | 75,000.00 |
API Access
Cellectar Biosciences Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();